Cheung Kong (Holdings) Ltd. (0001.HK) on Wednesday denied a media report that said Chairman Li Ka-shing had gone for an angioplasty procedure at a hospital in Hong Kong in January.
Next Magazine reported Wednesday that the tycoon had the surgery at Hong Kong Sanatorium and Hospital and was discharged two days later.
A spokeswoman for Cheung Kong, Li's Hong Kong-listed flagship company, said the report was untrue.
"Mr. Li hasn't undergone any angioplasty operation, nor is he planning to do so," she said. She added that Li isn't taking any heart or blood-related medication.
Angioplasty, also called percutaneous coronary intervention, is a medical procedure in which a balloon is used to open narrowed or blocked blood vessels of the heart.
-By Polly Hui, Dow Jones Newswires; 852-2802-7002; [email protected]